Lipocine (STU:2VT0) Other Long Term Assets : €0.02 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Lipocine Other Long Term Assets?

Lipocine's other long-term assets for the quarter that ended in Mar. 2024 was €0.02 Mil.

Lipocine's quarterly other long-term assets declined from Sep. 2023 (€0.02 Mil) to Dec. 2023 (€0.02 Mil) but then increased from Dec. 2023 (€0.02 Mil) to Mar. 2024 (€0.02 Mil).

Lipocine's annual other long-term assets declined from Dec. 2021 (€3.61 Mil) to Dec. 2022 (€3.09 Mil) and declined from Dec. 2022 (€3.09 Mil) to Dec. 2023 (€0.02 Mil).

Lipocine Other Long Term Assets Historical Data

The historical data trend for Lipocine's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipocine Other Long Term Assets Chart

Lipocine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.02

3.61

3.09

0.02

Lipocine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															3.06	3.02	0.02	0.02	0.02

Lipocine Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Lipocine (STU:2VT0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipocine Inc (STU:2VT0) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

LPCN:USA

Address

675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108

Website

http://www.lipocine.com

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

Lipocine (STU:2VT0) Headlines

No Headlines